CA2530345A1 - Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool - Google Patents

Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool Download PDF

Info

Publication number
CA2530345A1
CA2530345A1 CA002530345A CA2530345A CA2530345A1 CA 2530345 A1 CA2530345 A1 CA 2530345A1 CA 002530345 A CA002530345 A CA 002530345A CA 2530345 A CA2530345 A CA 2530345A CA 2530345 A1 CA2530345 A1 CA 2530345A1
Authority
CA
Canada
Prior art keywords
vitamin
amount
composition
alcohol
silymarin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002530345A
Other languages
English (en)
Inventor
Karol Wojewnik
Alicia Wojewnik
Peter Wojewnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFFECTLIVE Inc
Original Assignee
EFFECTLIVE INC.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EFFECTLIVE INC. filed Critical EFFECTLIVE INC.
Priority to CA002530345A priority Critical patent/CA2530345A1/fr
Publication of CA2530345A1 publication Critical patent/CA2530345A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002530345A 2005-12-15 2005-12-15 Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool Abandoned CA2530345A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002530345A CA2530345A1 (fr) 2005-12-15 2005-12-15 Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002530345A CA2530345A1 (fr) 2005-12-15 2005-12-15 Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool

Publications (1)

Publication Number Publication Date
CA2530345A1 true CA2530345A1 (fr) 2007-06-15

Family

ID=38162364

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002530345A Abandoned CA2530345A1 (fr) 2005-12-15 2005-12-15 Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool

Country Status (1)

Country Link
CA (1) CA2530345A1 (fr)

Similar Documents

Publication Publication Date Title
US20070196518A1 (en) Composition and Method for Mitigating a Negative Effect of Alcohol Consumption
US20050276839A1 (en) Appetite satiation and hydration beverage
WO1999051252A1 (fr) Procede et composition servant a ameliorer la circulation sanguine
US20190262414A1 (en) Natural formulation for treating hangover
WO2008021861A2 (fr) Boisson de réhydratation
ZA200604097B (en) Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences
US20100080863A1 (en) Dietary Composition and Method of Using the Same
US6967031B1 (en) Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
KR20140090453A (ko) 아로니아 추출물을 함유하는 숙취예방, 숙취해소 또는 간 보호용 조성물
US7879374B2 (en) Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers
CA3012021A1 (fr) Composition et methode pour l`attenuation des effets de la consommation d`alcool
CN103251698B (zh) 一种具有解酒保肝护胃功效的葛根饮液及其制法
KR100392876B1 (ko) 숙취제거용 음료 및 그의 제조 방법
JP4974553B2 (ja) アセトアルデヒド代謝促進剤
EP3463331B1 (fr) Combinaison de l-cystéine, d'acide ascorbique et de vitamine b3 pour prévenir et/ou réduire les symptômes d'une veisalgie
CA2530345A1 (fr) Composition et methode d'attenuation d'effets negatifs associes a la consommation d'alcool
EP4181693A1 (fr) Supplément nutritionnel, approprié pour une administration orale, comprenant de la dihydromyricétine, de la choline et une ou plusieurs vitamines ayant une activité antioxydante, pour une utilisation dans le maintien d'une fonction hépatique normale
BE1026122B1 (fr) Composition pour prévenir ou réduire les effets d'une intoxication alcoolique
KR100620093B1 (ko) 숙취의 예방 또는 치료용 조성물
KR100584891B1 (ko) 경구용 슈퍼옥사이드 디스뮤타제 제제인, 캔털루프 멜론추출물과 글리아딘 결합물을 숙취해소에 사용하는 방법
US20230181488A1 (en) Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia
EP3357541B1 (fr) Composition du méthylsulfonylméthane pour diminuer la teneur en alcool dans le sang
JP2022552311A (ja) 改善した二日酔い止め組成物、その調製及び使用
US20230052453A1 (en) Compositions and methods for relieving effects of alcohol consumption
US20240058411A1 (en) Composition for treating and/or preventing a hangover

Legal Events

Date Code Title Description
FZDE Dead